Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-07

Clinical Trial Update: Evaluation of FeNO During and Following Acute COPD Exacerbation

View source ↗

Summary

A study evaluating exhaled nitric oxide (FeNO) during and after acute COPD exacerbations was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University | Conditions: Chronic Obstructive Pulmonary Disease | Status: TERMINATED